Ontario Association of Cardiologists
  • About
    • Who We Are
    • Our History
    • Mission, Values & Goals
    • Initiatives & Successes
    • President’s Message
    • Board of Directors
  • Understanding Cardiology
    • Investing in Cardiology
    • Video Stories
      • Why the OAC Exists
      • Your Heart is Amazing!
      • Follow the Patient
      • A Day in the Life
      • A Patient’s Perspective
      • Cardiologists Add Value
      • Coalition of Ontario Doctors
  • Events
  • Membership
    • Membership Benefits
    • Sign-ups and Renewals
  • News
  • Resources
    • Definitions & Acronyms
    • Community Forums
    • Webinars
    • Echo Accreditation
    • Choosing Wisely Canada Campaign
    • Brand & Logo Guidelines
  • Contact Us
  • Sign In
    • Sign In
    • My Account

OAC Supports Recommendation to Publicly Fund the Use of Natriuretic Peptide Testing in Adults with Suspected Heart Failure

OAC Supports Recommendation to Publicly Fund the Use of Natriuretic Peptide Testing in Adults with Suspected Heart Failure

February 10, 2021

The Ontario Association of Cardiologists (OAC) supports a draft recommendation issued by Ontario Health (OH) calling for public funding of the use of natriuretic peptide (BNP or NT-proBNP) testing for the diagnosis of people with suspected heart failure in the community and emergency department settings.

At the present time, Ontario patients pay directly for this testing unless  it is performed as an inpatient or outpatient hospital service.  “The measurement of BNP or NT-proBNP is an accepted biomarker for the diagnosis and management of patients with heart failure.  The current lack of public funding for this testing in the community in Ontario is a major limitation to clinicians and their patients and requires adjustment”, states the OAC’s letter.

The draft recommendation is based on guidance from the Ontario Health Technology Advisory Committee, which has been studying the issue since 2019.  More information on the health technology assessment can be found at OH’s website: https://hqontario.ca/…/Use-of-B-Type-Natriuretic….

The OAC is calling on the Ministry of Health to accept and implement the recommendation immediately.  “The evidence is unequivocal that natriuretic peptide testing has clinical benefit, and is in accordance with patient preferences, patient care equity and cost effectiveness.  We urge the Ministry of Health to act on this recommendation and extend public funding for the expanded use of this important diagnostic and therapeutic decision-making tool in the interest of Ontario patients.”

To read the the OAC’s letter, click here: OAC Letter – Natriuretic Peptide (BNP or NT-proBNP) Testing (Feb. 9, 2021).

OH is requesting public and stakeholder feedback on the draft recommendation by February 24, 2021, which can be provided online here: https://survey.alchemer.com/s3/6148237/B-Type-Eng.

For more information, contact:

Ontario Association of Cardiologists
34 Eglinton Ave. West, Suite 410
Toronto, Ontario M4R 2H6
Tel: 416-487-0054
Toll-Free: 1-877-504-1239
E-mail: [email protected]
Web: www.ontarioheartdoctors.ca

Share this:
  • Facebook
  • Twitter
  • Email to a Friend

Related News

Abeona
March 11, 2026 by Amit Das
Registration Open: 2026 OAC Clinical Practice & Financial Management Seminar
March 4, 2026 by Tim Holman
Save the Date: OAC 2026 Clinical Practice & Financial Management Seminar
January 31, 2026 by Tim Holman
Category Posts
  • Registration Open: 2026 OAC Clinical Practice & Financial Management Seminar
  • Save the Date: OAC 2026 Clinical Practice & Financial Management Seminar
  • OAC participates in Ontario Budget 2026 consultations
  • OAC Participating in the 22nd Annual International Arrhythmia School — Member Discount Available
  • OAC Information Webinar – EQI Program Accreditation Requirements Update (2025)
  • OAC Information Webinar – Wednesday, November 5, 2025 at 8:00pm
  • 2025 Annual General Meeting of Members
  • OAC Now on Bluesky and Twitter
  • OAC Information Webinar – Wednesday, June 25, 2025 at 8:00pm
  • Investing in Cardiac Care: OAC’s Statement on the 2025 Ontario Budget
  • 2025 OAC Cardiology Clinical Practice & Financial Management Seminar: A Resounding Success
  • OAC Statement on Re-Election of Ontario Government and Cabinet Appointments
  • Cardiology, Career & Connection — April 26, 2025 in Toronto
  • Register for the CSE Echo Weekend – May 1-3, 2025 in Toronto
  • 2025 Cardiology Clinical Practice and Financial Management Seminar
  • Join the International Arrhythmia School 2025 in Collingwood!
X logo

Follow Us on X (Twitter)

Stay connected with the OAC for real-time advocacy updates,
clinical practice news, and upcoming events.

See Our Latest Posts

Protect, Maintain & Improve Cardiac Care in Ontario. Become a Member

Already a Member? Sign In

410 - 250A Eglinton Ave. East
Toronto, Ontario M4P 1K2

Tel: (416) 487-0054
Toll-Free: (877) 504-1239

E-mail: [email protected]

Quick Links
  • Contact Us
  • Mission, Values & Goals
  • Sign-ups and Renewals
  • Who We Are
  • Why the OAC Exists
  • Privacy Statement
  • Terms of Use
Find Us on Social Media

Copyright © Ontario Association of Cardiologists. All rights reserved.